3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Venous Thrombosis
2
Venous Thromboembolism
2
Pulmonary Embolism
2
Neoplasms
2
Multiple Myeloma
2
Urinary Bladder Neoplasms
1
Thrombosis
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Interventions
Standard of Care
9
Exercise
9
Educational Status
8
Practice Guidelines as Topic
7
Methods
7
Blood Specimen Collection
7
Early Intervention, Educational
6
Palliative Care
5
Interviews as Topic
5
Behavior Therapy
5
fludarabine
4
Surveys and Questionnaires
4
Physical Therapy Modalities
4
Cyclophosphamide
4
Magnetic Resonance Spectroscopy
3
Health Promotion
3
Granulocyte Colony-Stimulating Factor
3
pegylated granulocyte colony-stimulating factor
2
fludarabine phosphate
2
Whole-Body Irradiation
2
Therapeutic Touch
2
Stem Cell Transplantation
2
Restraint, Physical
2
Radiosurgery
2
Patient Navigation
2
Parenteral Nutrition
2
Low-Level Light Therapy
2
Etoposide
2
Cytarabine
2
Control Groups
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Hematologic Neoplasms
×
apixaban
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled